Mark Cuban’s drug company to add another branded med

Mark Cuban Cost Plus Drug Co. will sell Euthyrox, its 21st brand-name drug, in March. 

Advertisement

Euthyrox (levothyroxine) is Provell Pharmaceuticals’ FDA-approved treatment for hypothyroidism and pituitary thyrotropin in thyroid cancer patients. Mark Cuban’s drug company also sells brand-name medications from Pfizer, Bayer and Johnson & Johnson. 

The 20 other branded therapies Cost Plus Drugs offers:

  • Advair Diskus (fluticasone/salmeterol)
  • Brenzavvy (bexagliflozin)
  • CaroSpir (spironolactone)
  • Climara (estradiol)
  • Clomid (clomiphene citrate)
  • Dexamethasone Intensol (dexamethasone)
  • Duavee (conjugated estrogens/bazedoxifene)
  • Estring (estradiol)
  • GaviLyte-C (PEG 3350-KCl-Na bicarb-NaCl-Na sulfate)
  • Invokamet (canagliflozin-metformin HCl)
  • Invokamet XR (canagliflozin-metformin HCl)
  • Invokana (canagliflozin)
  • Nitro-Bid (nitroglycerin)
  • Premarin (conjugated estrogens)
  • Premphase (conjugated estrogens/medroxyprogesterone)
  • Prempro (conjugated estrogens/medroxyprogesterone)
  • Promethegan (promethazine HCl)
  • Tirosint (levothyroxine sodium)
  • Yaz (drospirenone/ethinyl estradiol)
  • Yusimry (adalimumab-aqvh)
Advertisement

Next Up in Pharmacy

  • CMS published plans Dec. 23 for its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” — or BALANCE…

Advertisement

Comments are closed.